Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФКГУ 1586 Окружной военный клинический госпиталь Московского военного округа Минобороны РФ
Список исп. литературыСкрыть список 1. Allen MH, Currier GW, Hughes DH et al. The expert consensus guideline series. Treatment of behavioral emergencies. Postgrad Med 2001; May (special number): 1–88. 2. Breier A, Meehan K, Birkett M et al. A doublе-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiat 2002; 59: 441–8. 3. Tran-Johnson TK, Sack DA, Marcus RN et al. Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial. J Clin Psychiat 2007; 68: 111–9. 4. Wright P, Birkett M, David SR et al. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiat 2001; 158: 1149–51. 5. Battaglia J, Lindborg SR, Alaka K et al. Calming vs sedative effects of intramuscular olanzapine in agitated patients. Am J Emerg Med 2003; 21: 192–8. 6. Heel RC, Brogden RN, Speight TM, Avery GS. Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent. Drugs 1978; 15: 198–217. 7. Chakrabarti A, Bagnall A, Chue P et al. Loxapine for schizophrenia. Cochrane Database Syst Rev 2007; 4: CD 001943. 8. Paprocki J, Versiani M. A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia. Curr Ther Res Clin Exp 1977; 21: 80–100. 9. Fruensgaard K, Korsgaard S, Jorgensen H, Jensen K. Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study. Acta Psychiat Scand 1977; 56: 256–64. 10. Dubin WR, Weiss KJ. Rapid tranquilization: a comparison of thiothixene with loxapine. J Clin Psychiat 1986; 47: 294–7. 11. Gaussares C, Gerard H, Bosc M. Interest in injectable Loxapine for severe agitation. Inf Psychiat 1989; 69: 656–60. 12. Bourdinard V, Pochard F. Survey of management methods for patients in a state of agitation at admissions and emergency departments in France. Encephale 2003; 29: 89–98. 13. Alderfer BS, Allen MH. Treatment of agitation in bipolar disorder across the life cycle. J Clin Psychiat 2003; 64 (Suppl. 4): 3–9. 14. Glazer WM. Does loxapine have «atypical» properties? Clinical evidence. J Clin Psychiat 1999; 60 (Suppl. 10): 42–6. 15. Spyker DA, Munzar P, Cassella JV. Pharmacokinetics of loxapine following inhalation of a thermally generated aerosol in healthy volunteers. J Clin Pharmacol 2010; 50: 169–79. 16. Rabinowitz JD, Lloyd PM, Munzar P et al. Ultrafast absorption of amorphous pure drug aerosols via deep lung inhalation J Pharm Sci 2006; 95: 2438–51. 17. Rabinowitz JD, Wensley M, Lloyd P et al. Fast onset medications through thermally generated aerosols. J Pharmacol Exp Ther 2004; 309: 769–75. 18. Spyker DA, Munzar P, Cassella JV. Pharmacokinetics of loxapine following inhalation of a thermally generated aerosol in healthy volunteers. J Clin Pharmacol 2010; 50: 169–79. 19. Noymer P, Myers D, Glazer M et al. The Staccato system: inhaler design characteristics for rapid treatment of CNS disorders. Resp Drug Deliv 2010; 1: 11–20. 20. Nordstrom K. Inhaled loxapine for acute agitation in schizophrenia and bipolar disorder. Future Nerol 2009; 4: 539–45. 21. Cassella J, Spyker D, Kwentus J et al. Rapid Improvement in the Five-Item PANSS-EC Scale for Agitation With Inhaled Loxapine (AZ-004). Poster presentation, Session II-34. 50th Meeting of the NCDEU. Boca Raton. Florida 2010; 14–7. 22. Citrome L. Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. J Clin Psychiat 2007; 68: 1876–85. 23. Allen MH, Currier GW. Use of restraints and pharmacotherapy in academic psychiatric emergency services. Gen Hosp Psychiat 2004; 26: 42–9.